Development of Cytolytic Iridium-Complexed Octaarginine Peptide Albumin Nanomedicine for Hepatocellular Carcinoma Treatment
This study demonstrated the combined advantages of a novel membrane-active oncolytic peptide nanomedicine and precise drug delivery enabled by arterial infusion technology for the interventional treatment of liver cancer.
Authors
- Yong Jin (ORCID: https://orcid.org/0000-0003-2536-2270)
- Xingwei Sun (ORCID: https://orcid.org/0000-0002-6639-145X)
- Shuangshuang Ji
- Hao Zhang (ORCID: https://orcid.org/0000-0003-2300-1404)
- Liang Yin (ORCID: https://orcid.org/0000-0001-7653-7718)
- Fei Hao (ORCID: https://orcid.org/0000-0002-3944-1220)
- Di Wang (ORCID: https://orcid.org/0009-0001-0371-010X)
- Shiwei Chang
Institutions
- Soochow University (CN)
- Suzhou Institute of Nano-tech and Nano-bionics (CN)
- Second Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/ijn.s502257
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health
- Government of Jiangsu Province